Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (NYSE: IFF) is a global leader in sensory experiences and specialty ingredients, serving industries from food technology to pharmaceutical solutions. This dedicated news hub provides investors and industry professionals with essential updates on IFF developments, including earnings reports, strategic partnerships, and scientific breakthroughs.
Key resources include: Quarterly financial results, innovation announcements in flavors/fragrances, bioscience advancements, and sustainability initiatives. Our curated collection ensures access to verified press releases and market analyses that impact IFF's position in the $120B+ specialty chemicals sector.
Bookmark this page for real-time updates on IFF's product launches, regulatory milestones, and leadership changes. Combine technical insights with strategic context to make informed decisions about this NYSE-listed innovator.
IFF (NYSE: IFF) has announced that Executive Vice President and CFO Glenn Richter will speak at the Consumer Analyst Group of New York's annual conference on February 24, 2022. His pre-recorded presentation is set to begin at 3:00 p.m. ET. A replay of the session will be available later on ir.iff.com. IFF is a leader in the food, beverage, scent, health, and biosciences sectors, creating solutions that promote a better world.
IFF (NYSE: IFF) has appointed Barry A. Bruno as an independent director on its Board, effective February 8, 2022. Bruno, currently the Chief Marketing Officer at Church & Dwight, brings extensive leadership experience in global consumer brands. The Board will now have 14 members following this appointment, which follows a cooperation agreement with Icahn Capital LP, which recommended Bruno. His addition is expected to enhance IFF's strategic direction amid ongoing market opportunities.
International Flavors & Fragrances (IFF) reported strong financial results for Q4 and full year 2021, with Q4 sales reaching $3.0 billion, a 139% increase year-over-year. The full year sales were $11.66 billion, up 129%. Adjusted EPS for Q4 was $1.10, while full year adjusted EPS was $5.63. Despite inflationary pressures affecting margins, the company achieved double-digit growth across all business segments. IFF expects 2022 sales between $12.3 billion and $12.7 billion, with adjusted operating EBITDA of $2.5 to $2.6 billion.
IFF (NYSE:IFF) will release its fourth quarter and full year 2021 earnings on February 9, 2022, after market close. A live webcast for discussion of results and outlook will follow on February 10, 2022, at 9:00 a.m. ET. Investors can access the webcast and presentation on the Company’s website. IFF is a leader in food, beverage, scent, and biosciences, offering innovative solutions globally.
On February 14, 2022, IFF appointed Frank Clyburn as CEO, succeeding Andreas Fibig. Clyburn, previously President of Human Health at Merck, boasts extensive experience in global business operations and leadership. His tenure at Merck involved full P&L responsibility for a $48 billion business and significant achievements in oncology. The transition comes alongside the separation of the Chairman and CEO roles, with Dale Morrison becoming non-executive Chairman. This change aims to enhance IFF’s strategic execution, driven by Clyburn's expertise in customer relations and operational discipline.
IFF (NYSE: IFF) and SleepScore Labs have unveiled a new scent solution aimed at enhancing sleep quality, following their 2020 partnership. This innovative scent, developed through comprehensive studies, demonstrated objective sleep improvements, including faster sleep onset and increased duration. The solution will be showcased at CES 2022 in Las Vegas. With 70% of the developed world affected by sleep issues, IFF and SleepScore's collaboration utilizes data-driven approaches to offer scientifically validated sleep solutions.
IFF (NYSE: IFF) announced a quarterly cash dividend of $0.79 per share, payable on January 7, 2022, to shareholders on record as of December 28, 2021. This declaration reflects the company's commitment to returning value to its shareholders while continuing to innovate in the food, beverage, scent, and biosciences sectors. As an industry leader, IFF combines science and creativity to deliver high-quality solutions.
Cabot Corporation (NYSE: CBT) has signed a Memorandum of Understanding (MOU) with IFF Health and Biosciences to develop and commercialize sustainable reinforcing additives for rubber products. This collaboration aims to reduce greenhouse gas emissions and increase renewable bio-based content in rubber applications. Utilizing IFF’s Nuvolve™ engineered polysaccharide, developed from European sugar beets, Cabot will lead the project, integrating it with its reinforcing carbons. This partnership aligns with Cabot's commitment to sustainability and innovation in the rubber industry.
IFF announced a substantial investment of $87 million to expand its flavors manufacturing facility in Karawang, Indonesia. This facility, the largest in Greater Asia, enhances IFF's capabilities to meet the growing demand for flavor technology. The 12,800m2 state-of-the-art facility focuses on efficiency, sustainability, and quality control, contributing to IFF's strategy of targeting emerging markets in Asia. With this investment, IFF aims to capitalize on the significant growth potential in the region, expected to account for half of global consumption growth in the next decade.
FAQ
What is the current stock price of International Flavors&Fragranc (IFF)?
What is the market cap of International Flavors&Fragranc (IFF)?
